The prognostic and predictive impact of low estrogen receptor expression in early breast cancer: a systematic review and meta-analysis

This is the authors' abstract. We don't add key points for this paper.

The current evidence suggests that ER-low breast cancer has a more similar outcome to ER-negative than to ER-positive breast cancer in terms of DFS and OS. ER-low expression seems also to have a predictive role regarding NeoCT. Considering the certainty of current evidence categorized as low to moderate, our results urge the need for well-designed prospective studies investigating the molecular background and the most appropriate treatment strategy for ER-low expressing breast cancer.